Navigation Links
MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy
Date:5/23/2013

SAN DIEGO, May 23, 2013 /PRNewswire/ -- MedVantx, Inc., the company that has pioneered a unique direct to consumer pharmaceutical distribution channel announced today the Company has completed a major expansion of its home delivery platform to manage $1.5B in pharmaceutical products and the upgrade of its systems to offer a level of quality akin to cGMP facilities in its specialty home delivery pharmacy in Sioux Falls, SD. The Company provides leading pharmaceutical manufacturers, physicians, health systems and payors novel distribution services, as well as home delivery services to consumers nationwide via its state of the art pharmaceutical distribution facility, MedVantx Pharmacy Services.

"MedVantx is extremely excited to have achieved these significant company milestones," stated Ron Bertsch , R.Ph., General Manager of MedVantx Pharmacy Services.  "We have grown to become one of the largest independent home delivery pharmacies in the U.S. and cGMPs define a level of quality typically only required of pharmaceutical manufacturers.  Although we are not a drug manufacturer, we wanted to challenge ourselves to meet the highest quality standards of the industry in our pharmacy.  Based on the positive response from our large pharmaceutical customers, we have met that challenge."

Adherence to the more than 200 cGMP provisions assures strong quality management systems, establishment of robust operating procedures, and the detection and investigation of product quality deviations.  This formal system of controls, when adequately put into practice, helps to prevent deviations, failures and errors.  These quality systems allow companies like MedVantx to use modern technologies and innovative approaches to achieve higher quality through continual improvement. 

"This announcement comes upon the completion of a significant facility expansion that included major enhancements to contingency planning, data and facility security, secure warehouse space and a new high volume single order unit of use prescription fulfillment capability.  MedVantx has also incorporated a Warehouse Management System to provide total segregation and accountability in the management of inventory," added Mr. Bertsch.

"MedVantx is one of only 32 VIPPs accredited pharmacies in the U.S. and our use of cGMP standards enables us to offer an even higher level of quality to our customers," stated Robert Feeney , Founder and Chief Executive Officer of MedVantx.  "The Prescription Assistance, Specialty Pharmacy and Cold Chain business is growing rapidly with industry revenues which are expected to exceed $160 billion globally in 2013.  This rapid growth is coming at a time of significant supply chain consolidation and customers are seeking new channels.  MedVantx has carved-out a very specialized niche in the marketplace based on full financial transparency, mass customization techniques, and the ability to provide high-quality, novel solutions, for industry partners as well as consumers," added Mr. Feeney. 

About MedVantx, Inc.

MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing helpful information to benefit patients, physicians, health plans, employers and manufacturers. The MedStart™ Connect program provides for a fully-automated, integrated, point-of-care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel – the physician office sample closet. MedStart Connect includes free initial therapy samples of prescription and over-the-counter medication at the point of care, a consumer helpline providing drug information, adherence management services, and convenient consumer home delivery through its mail order pharmacy.  MedVantx Pharmacy Services, a wholly owned subsidiary of MedVantx, Inc., operates a state of the art pharmaceutical distribution facility located in Sioux Falls, SD.

MedVantx Pharmacy Services Contact:
Ron Bertsch
(605) 978-3930
ron.bertsch@medvantx.com  

MedVantx Contact:
JD Haldeman
(858) 625-2990 ext. 130
JD.Haldeman@MedVantx.com


'/>"/>
SOURCE MedVantx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
2. MedVantx Names New VP Employer Solutions and Workplace Health
3. MedVantx Pharmacy Services Receives Coveted VIPPS Accreditation (Verified Internet Pharmacy Practice Sites)
4. MedVantx Achieves Significant Milestone of Providing Over $600 Million of Specialty Pharmacy Prescription Medications to Consumers
5. FastMed Urgent Care and MedVantx Offer Consumers First Ever Access to Free Samples of Medications through an Automated Medication Cabinet Across North Carolinas Largest Network of Urgent Care Centers
6. Greenville Hospital System Achieves Dramatic Improvement in Hand Hygiene Compliance Rates Using New Technology from DebMed®
7. Acuo Technologies Grows European Business and Achieves Successful Connectathon Results in Bern, Switzerland
8. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
9. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
10. South Carolinas Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Tennessee Stop-Sale System Achieves Significant Results In Battle Against Meth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
Breaking Medicine News(10 mins):